U.S. Stock Earnings Reports & Market News
Idexx Laboratories Inc FY2025Q3 Revenue Increased 13.2% YoY
Executive Summary Idexx Laboratories Inc, traded on NASDAQ under the ticker IDXX,…
LSCC FY2025Q3 Revenue Decreased 5.7% YoY, Net Income Up 53.8%
Executive Summary Lattice Semiconductor Corporation (LSCC) reported its fiscal third quarter of…
PEG Inc FY2025Q3 Revenue Up 22.2% to $3.226B, Net Income $622M
Executive Summary In the third quarter of fiscal year 2025, PEG Inc…
Pfizer Inc FY2024 Q3 Financial Analysis: Revenue Up 31.4%, Net Income $4.48B
Executive Summary Pfizer Inc reported robust financial performance for Q3 FY2024, with…
Caterpillar Inc FY2025Q3 Revenue Increased 9.5% to $17.64B, Net Income Remains Strong at $2.29B
Executive Summary This comprehensive financial report analyzes Caterpillar Inc.’s performance for the…
PTL Limited FY2025 Q2 Financial Analysis: Revenue Increased 14.1%, Net Income Up 0.1%
Executive Summary PTL Limited reported its fiscal second quarter of 2025 with…
Spire Global Inc FY2024 Q2 Financial Analysis: Revenue Decreased 10.4%
Executive Summary In the second quarter of fiscal year 2024, Spire Global…
Intellia Therapeutics Inc FY2025 Q2 Net Loss Decreased 26.4%
Executive Summary In the second quarter of fiscal year 2025, Intellia Therapeutics…
Ovid Therapeutics Inc FY2025Q2 Revenue Increased 271% Year-over-Year
Executive Summary In the second quarter of fiscal year 2025, Ovid Therapeutics…
CIMG Inc FY2025 Q2 Financial Results: Net Income Decreased 37%, Cash Flow Negative
Executive Summary In the second quarter of fiscal year 2025, CIMG Inc.…
Natural Resource Partners LP Q2 FY2025: Net Income Increased 44% YoY to $74.5M
Executive Summary In the second quarter of 2025, Natural Resource Partners LP…
NEXSTAR MEDIA GROUP INC FY2025 Q2 Revenue Increased 15% Compared to Prior Year
Executive Summary In the second quarter of fiscal year 2025, NEXSTAR MEDIA…
OMEX FY2025Q2 Largest Change: Net Loss Decreased by 89.4%
Executive Summary Odyssey Marine Exploration Inc. (OMEX) reported its financial results for…
Intellia Therapeutics Inc FY2025Q1 Net Loss Decreased 6.4%
Executive Summary In the first quarter of fiscal year 2025, Intellia Therapeutics…
Ovid Therapeutics Inc FY2025Q1 Revenue Decreased 12.2% Compared to Prior Year
Executive Summary Ovid Therapeutics Inc., a biopharmaceutical company focused on developing small…
Natural Resource Partners LP FY2025Q1 Revenue Decreased 22.4% Compared to Prior Year
Executive Summary In the first quarter of fiscal year 2025, Natural Resource…
Nexstar Media Group Inc FY2025Q1 Revenue Increased 4.2% Compared to Prior Year
Executive Summary Nexstar Media Group Inc (NXST) reported its first quarter of…
Odyssey Marine Exploration Inc FY2025Q1 Revenue Decreased 33.8% Compared to Prior Year
Executive Summary Odyssey Marine Exploration Inc (OMEX) reported a significant decline in…
Intellia Therapeutics Inc FY2024 Net Loss Decreased by 8.0%, Reflecting Improved Cost Management
Executive Summary For the fiscal year 2024, Intellia Therapeutics Inc (NTLA) reported…
Ovid Therapeutics Inc FY2024 Net Loss Decreased 49.5%
Executive Summary Ovid Therapeutics Inc., traded on NASDAQ under the ticker OVID,…
Nexstar Media Group Inc FY2024 Revenue Increased 9.6% Year-Over-Year
Executive Summary Nexstar Media Group Inc (NXST) reported a significant increase in…
Onity Group Inc FY2024 Financial Report: Revenue Decreased 6.4%, Net Income Up 86%
Executive Summary Onity Group Inc reported fiscal year 2024 with total revenue…
Nurix Therapeutics FY2025Q3 Revenue Decreased 37.3% Year-Over-Year
Executive Summary This comprehensive financial analysis provides an in-depth review of Nurix…
Middlesex Water Company FY2025Q3 Revenue Increased 4.4% YoY
Executive Summary In the third quarter of fiscal year 2025, Middlesex Water…
Nurix Therapeutics Inc FY2025Q2 Revenue Increased 45.0% YoY, Largest Change in Financial Metrics
Executive Summary Nurix Therapeutics Inc (NASDAQ: NRIX) reported a significant year-over-year increase…
Nektar Therapeutics FY2025 Q2 Financial Results: Net Loss Decreased 20.7%
Executive Summary In the second quarter of fiscal year 2025, Nektar Therapeutics…
Nurix Therapeutics Inc FY2025Q1 Revenue Increased 11% Compared to Prior Quarter
Executive Summary Nurix Therapeutics Inc (NASDAQ: NRIX) reported its financial results for…
Nektar Therapeutics FY2025Q1 Revenue Decreased 52.8% Compared to Prior Year
Executive Summary Nektar Therapeutics, traded under the ticker NKTR, reported its financial…
NiSun International Enterprise Development Group Co Ltd FY2024 Revenue Increased 12.2%
Executive Summary NiSun International Enterprise Development Group Co., Ltd (NISN) reported a…
NEWT FY2024 Net Income Decreased 7.4% Year-Over-Year, Company Outlook Remains Cautious
Key Metrics Comparison Metric FY2024 FY2023 Change Net Income ($ Thousands) 50,853…